Gaurav Narula

Emergency Medicine | Hospital Medicine | Bariatric Medicine

2900 W Oklahoma Ave
Milwaukee, WI 53215

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

Clinical Relevance of Genomics Defined WHO5 Subtypes of Pediatric B-ALL in the Context of Measurable Residual Disease-Directed Risk-Based Therapy.

Clinical Relevance of Genomics Defined WHO5 Subtypes of Pediatric B-ALL in the Context of Measurable Residual Disease-Directed Risk-Based Therapy.

Journal: JCO global oncology

Published: September 03, 2026

PREPARE ALL: An Artificial Intelligence Tool for Predicting Relapse in Children With Acute Lymphoblastic Leukemia.

PREPARE ALL: An Artificial Intelligence Tool for Predicting Relapse in Children With Acute Lymphoblastic Leukemia.

Journal: JCO clinical cancer informatics

Published: January 21, 2026

Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016-2022).

Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016-2022).

Journal: The Lancet regional health. Southeast Asia

Published: January 17, 2026

Nutritional status at diagnosis and follow-up and its impact on short-term clinical outcome in children with cancer: a real-world report from India.

Nutritional status at diagnosis and follow-up and its impact on short-term clinical outcome in children with cancer: a real-world report from India.

Journal: Ecancermedicalscience

Published: November 04, 2025

Prevalence and Prognostic Impact of NPM1 Mutation in Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Cancer Centre in India.

Prevalence and Prognostic Impact of NPM1 Mutation in Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Cancer Centre in India.

Journal: Clinical lymphoma, myeloma & leukemia

Published: September 27, 2025

Global access to commercial CAR T cells: A cross-sectional study of health technology assessment in the G20.

Global access to commercial CAR T cells: A cross-sectional study of health technology assessment in the G20.

Journal: Blood

Published: July 21, 2025

Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries.

Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries.

Journal: Blood

Published: July 21, 2025

Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.

Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.

Journal: Blood cancer journal

Published: May 20, 2025

Combination of fixed low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical Hodgkin lymphoma.

Combination of fixed low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical Hodgkin lymphoma.

Journal: British journal of haematology

Published: January 28, 2025

Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India.

Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India.

Journal: The Lancet regional health. Southeast Asia

Published: January 25, 2025

Changing paradigms in pediatric cancer care - the contemporary landscape and perspectives for India.

Changing paradigms in pediatric cancer care - the contemporary landscape and perspectives for India.

Journal: Ecancermedicalscience

Published: January 13, 2025

Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.

Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.

Journal: Blood cancer journal

Published: December 17, 2024

Showing 1-12 of 90

Last Updated: 09/26/2026